- $409.81m
- $252.30m
- $41.29m
- 56
- 24
- 66
- 47
REG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Grant of Options, RSUs and PSUs and PDMR Dealing
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Filing of form 10-K for FY ended December 31, 2023
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Reports Q4 & FY 2023 Financial Results
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - TR-1: Notification of major holdings
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Preliminary FY Results & 2024 Guidance
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Total Voting Rights
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Exercise of options and PDMR dealing
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - TR-1: Notification of major holdings
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Notice of Results
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Total Voting Rights
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Director/PDMR Shareholding
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Holding(s) in Company
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Signing of Strategic Platform License
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - TR-1: Notification of major holdings
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Filing of Form 8-K
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Signing of Strategic Platform License
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Preliminary Unaudited Q4 and FY 2023 Results
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Grant of Options and PDMR Dealing
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Signing of Strategic Platform License
Announcement